BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Hudson Bay Capital Management LP's Holding History (CIK: 0001393825)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,017,374 Value ($000) $7,936 Avg Close $7.23 Range $6.00 - $8.17
Q2 2025
Shares 304,772 Value ($000) $2,731 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 498,679 Value ($000) $3,740 Avg Close $8.07 Range $6.96 - $9.50
Q2 2024
Shares 180,000 Value ($000) $1,112 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 300,000 Value ($000) $1,524 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 130,000 Value ($000) $779 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 65,000 Value ($000) $460 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 64,700 Value ($000) $455 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 42,500 Value ($000) $354 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 25,000 Value ($000) $287 Avg Close $12.47 Range $10.36 - $14.50
Q1 2019
Shares 140,000 Value ($000) $1,140 Avg Close $8.56 Range $7.10 - $9.95
Q4 2018
Shares 130,000 Value ($000) $1,049 Avg Close $7.78 Range $6.43 - $9.71
Q3 2018
Shares 220,000 Value ($000) $1,679 Avg Close $6.72 Range $5.41 - $8.13
Q2 2018
Shares 300,000 Value ($000) $1,719 Avg Close $5.50 Range $4.53 - $6.67
Q1 2018
Shares 560,000 Value ($000) $2,671 Avg Close $5.14 Range $4.25 - $5.92